Antipsychotics use in children and adolescents: An on-going challenge in clinical practice

Efficacy and Safety of Quetiapine in Children and Adolescents With Mania Associated With Bipolar I Disorder

(2013) Sanjeev Pathak et al.   JOURNAL OF CLINICAL PSYCHIATRY

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia

(2013) Jon McClellan et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children

(2011) Tamara Pringsheim et al.   DRUG SAFETY

Mortality in Children and Adolescents Prescribed Antipsychotic Medication

(2011) Fariz A. Rani et al.   DRUG SAFETY

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

(2011) M. De Hert et al.   EUROPEAN PSYCHIATRY

QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone

(2011) Christoph U. Correll et al.   JOURNAL OF CLINICAL PSYCHIATRY

Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome

(2011) Mariangela Gulisano et al.   NEUROLOGICAL SCIENCES

Effectiveness and safety of antipsychotics in early onset psychoses: A long-term comparison

(2011) Carlo Cianchetti et al.   PSYCHIATRY RESEARCH

Drug-induced Movement Disorders in Children

(2009) Donald L. Gilbert   Annals of the New York Academy of Sciences

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder

(2009) Melissa P DelBello et al.   BIPOLAR DISORDERS

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study

(2009) Magali Haas et al.   BIPOLAR DISORDERS

Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study

(2009) Fariz A. Rani et al.   DRUG SAFETY

Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia

(2009) Angèle Consoli et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia

(2009) Magali Haas et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

The Role of Psychosocial Interventions in Bipolar II Disorder

(2009) Holly A. Swartz   JOURNAL OF CLINICAL PSYCHIATRY

Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder

(2009) Silzá Tramontina et al.   JOURNAL OF CLINICAL PSYCHIATRY

Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole

(2009) Robert L. Findling et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

StaR Child Health: an initiative for RCTs in children

(2009) Terry P Klassen et al.   LANCET

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia

(2008) Robert L. Findling et al.   AMERICAN JOURNAL OF PSYCHIATRY

QTc Changes after 6 Months of Second-Generation Antipsychotic Treatment in Children and Adolescents

(2008) María J. de Castro et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder

(2008) Melissa P. DelBello et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Treating Disruptive Behavior Disorders with Risperidone: A 1-Year, Open-Label Safety Study in Children and Adolescents

(2008) Magali Haas et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study

(2008) Sanjiv Kumra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Antipsychotics in the treatment of autism

(2008) David J. Posey et al.   JOURNAL OF CLINICAL INVESTIGATION

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Ludmila Kryzhanovskaya et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Antipsychotic Treatment in Child and Adolescent First-Episode Psychosis: A Longitudinal Naturalistic Approach

(2007) Josefina Castro-Fornieles et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Randomized Controlled Pilot Study of Quetiapine in the Treatment of Adolescent Conduct Disorder

(2007) Daniel F. Connor et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY